US Stock MarketDetailed Quotes

CSTL Castle Biosciences

Watchlist
  • 21.680
  • -3.600-14.24%
Close Feb 28 16:00 ET
  • 22.300
  • +0.620+2.86%
Post 19:48 ET
618.19MMarket Cap34.97P/E (TTM)

Castle Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
51.09%332.07M
30.54%86.31M
39.50%85.78M
73.53%87M
73.59%72.97M
60.38%219.79M
72.47%66.12M
66.15%61.49M
43.92%50.14M
56.55%42.04M
Operating revenue
51.09%332.07M
30.54%86.31M
39.50%85.78M
73.53%87M
73.59%72.97M
60.38%219.79M
72.47%66.12M
66.15%61.49M
43.92%50.14M
56.55%42.04M
Cost of revenue
33.84%60.21M
30.27%16.18M
37.90%15.61M
31.30%14.52M
36.46%13.89M
40.53%44.98M
30.49%12.42M
27.77%11.32M
43.87%11.06M
71.30%10.18M
Gross profit
55.52%271.86M
30.60%70.13M
39.86%70.17M
85.47%72.48M
85.47%59.08M
66.43%174.81M
86.33%53.7M
78.23%50.17M
43.93%39.08M
52.36%31.86M
Operating expense
8.41%263.19M
11.33%66.08M
8.83%65.09M
12.01%67.47M
1.85%64.55M
23.76%242.78M
14.25%59.36M
20.01%59.81M
16.92%60.24M
47.86%63.38M
Selling and administrative expenses
11.04%200.05M
13.33%49.97M
13.18%50.5M
14.34%51.09M
3.71%48.5M
25.98%180.15M
14.74%44.09M
21.82%44.62M
19.16%44.68M
53.55%46.76M
-Selling and marketing expense
8.63%123.47M
12.79%30.41M
4.70%29.84M
15.66%32.68M
2.00%30.54M
--113.66M
--26.96M
27.28%28.5M
30.91%28.25M
64.34%29.95M
-General and administrative expense
15.17%76.58M
14.17%19.55M
28.16%20.66M
12.08%18.41M
6.74%17.95M
--66.5M
--17.13M
13.24%16.12M
3.22%16.43M
37.48%16.82M
Research and development costs
-2.94%52.04M
-9.40%11.77M
-4.64%12.32M
6.22%14.14M
-4.06%13.81M
19.41%53.62M
14.90%12.99M
18.48%12.92M
11.59%13.31M
33.75%14.39M
Depreciation amortization depletion
23.22%11.11M
91.11%4.34M
0.00%2.27M
-0.04%2.25M
1.13%2.25M
9.04%9.01M
2.53%2.27M
-1.47%2.27M
7.20%2.25M
34.83%2.22M
-Depreciation and amortization
23.22%11.11M
91.11%4.34M
0.00%2.27M
-0.04%2.25M
1.13%2.25M
9.04%9.01M
2.53%2.27M
-1.47%2.27M
7.20%2.25M
34.83%2.22M
Operating profit
112.75%8.67M
171.58%4.05M
152.69%5.08M
123.69%5.01M
82.64%-5.47M
25.42%-67.98M
75.54%-5.66M
55.55%-9.64M
13.18%-21.16M
-43.58%-31.52M
Net non-operating interest income expense
16.27%12.34M
5.23%3.28M
15.76%3.2M
19.95%2.87M
27.87%2.98M
168.59%10.61M
37.25%3.12M
115.00%2.77M
554.64%2.4M
8,537.04%2.33M
Non-operating interest income
21.59%12.92M
8.11%3.37M
22.93%3.4M
31.05%3.14M
28.25%3M
167.72%10.62M
37.10%3.12M
114.15%2.77M
548.38%2.4M
7,686.67%2.34M
Non-operating interest expense
5,145.45%577K
4,500.00%92K
9,950.00%201K
8,900.00%270K
250.00%14K
-35.29%11K
-50.00%2K
-66.67%2K
-25.00%3K
33.33%4K
Other net income (expense)
555K
Special income (charges)
--0
----
----
----
----
--0
----
----
----
----
-Less：Restructuring and merger&acquisition
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
--555K
----
----
----
----
----
----
----
----
----
Income before tax
137.59%21.56M
410.31%7.89M
220.50%8.28M
142.03%7.89M
91.47%-2.49M
16.75%-57.37M
87.64%-2.54M
66.06%-6.87M
-420.42%-18.76M
-19.20%-29.19M
Income tax
3,186.14%3.32M
-4,471.79%-1.71M
18,690.63%6.01M
-6,562.50%-1.03M
221.43%45K
105.72%101K
-31.58%39K
32K
100.82%16K
-89.55%14K
Net income
131.75%18.25M
471.71%9.59M
132.86%2.27M
147.50%8.92M
91.32%-2.53M
14.41%-57.47M
87.49%-2.58M
65.90%-6.91M
-1,039.38%-18.78M
-18.60%-29.2M
Net income continuous Operations
131.75%18.25M
471.71%9.59M
132.86%2.27M
147.50%8.92M
91.32%-2.53M
14.41%-57.47M
87.49%-2.58M
65.90%-6.91M
-1,039.38%-18.78M
-18.60%-29.2M
Minority interest income
Net income attributable to the parent company
131.75%18.25M
471.71%9.59M
132.86%2.27M
147.50%8.92M
91.32%-2.53M
14.41%-57.47M
87.49%-2.58M
65.90%-6.91M
-1,039.38%-18.78M
-18.60%-29.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
131.75%18.25M
471.71%9.59M
132.86%2.27M
147.50%8.92M
91.32%-2.53M
14.41%-57.47M
87.49%-2.58M
65.90%-6.91M
-1,039.38%-18.78M
-18.60%-29.2M
Basic earnings per share
130.84%0.66
477.78%0.34
130.77%0.08
145.71%0.32
91.82%-0.09
17.05%-2.14
88.46%-0.09
66.23%-0.26
-1,066.67%-0.7
-13.40%-1.1
Diluted earnings per share
128.97%0.62
455.56%0.32
130.77%0.08
144.29%0.31
91.82%-0.09
17.05%-2.14
88.46%-0.09
66.23%-0.26
-1,066.67%-0.7
-13.40%-1.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 51.09%332.07M30.54%86.31M39.50%85.78M73.53%87M73.59%72.97M60.38%219.79M72.47%66.12M66.15%61.49M43.92%50.14M56.55%42.04M
Operating revenue 51.09%332.07M30.54%86.31M39.50%85.78M73.53%87M73.59%72.97M60.38%219.79M72.47%66.12M66.15%61.49M43.92%50.14M56.55%42.04M
Cost of revenue 33.84%60.21M30.27%16.18M37.90%15.61M31.30%14.52M36.46%13.89M40.53%44.98M30.49%12.42M27.77%11.32M43.87%11.06M71.30%10.18M
Gross profit 55.52%271.86M30.60%70.13M39.86%70.17M85.47%72.48M85.47%59.08M66.43%174.81M86.33%53.7M78.23%50.17M43.93%39.08M52.36%31.86M
Operating expense 8.41%263.19M11.33%66.08M8.83%65.09M12.01%67.47M1.85%64.55M23.76%242.78M14.25%59.36M20.01%59.81M16.92%60.24M47.86%63.38M
Selling and administrative expenses 11.04%200.05M13.33%49.97M13.18%50.5M14.34%51.09M3.71%48.5M25.98%180.15M14.74%44.09M21.82%44.62M19.16%44.68M53.55%46.76M
-Selling and marketing expense 8.63%123.47M12.79%30.41M4.70%29.84M15.66%32.68M2.00%30.54M--113.66M--26.96M27.28%28.5M30.91%28.25M64.34%29.95M
-General and administrative expense 15.17%76.58M14.17%19.55M28.16%20.66M12.08%18.41M6.74%17.95M--66.5M--17.13M13.24%16.12M3.22%16.43M37.48%16.82M
Research and development costs -2.94%52.04M-9.40%11.77M-4.64%12.32M6.22%14.14M-4.06%13.81M19.41%53.62M14.90%12.99M18.48%12.92M11.59%13.31M33.75%14.39M
Depreciation amortization depletion 23.22%11.11M91.11%4.34M0.00%2.27M-0.04%2.25M1.13%2.25M9.04%9.01M2.53%2.27M-1.47%2.27M7.20%2.25M34.83%2.22M
-Depreciation and amortization 23.22%11.11M91.11%4.34M0.00%2.27M-0.04%2.25M1.13%2.25M9.04%9.01M2.53%2.27M-1.47%2.27M7.20%2.25M34.83%2.22M
Operating profit 112.75%8.67M171.58%4.05M152.69%5.08M123.69%5.01M82.64%-5.47M25.42%-67.98M75.54%-5.66M55.55%-9.64M13.18%-21.16M-43.58%-31.52M
Net non-operating interest income expense 16.27%12.34M5.23%3.28M15.76%3.2M19.95%2.87M27.87%2.98M168.59%10.61M37.25%3.12M115.00%2.77M554.64%2.4M8,537.04%2.33M
Non-operating interest income 21.59%12.92M8.11%3.37M22.93%3.4M31.05%3.14M28.25%3M167.72%10.62M37.10%3.12M114.15%2.77M548.38%2.4M7,686.67%2.34M
Non-operating interest expense 5,145.45%577K4,500.00%92K9,950.00%201K8,900.00%270K250.00%14K-35.29%11K-50.00%2K-66.67%2K-25.00%3K33.33%4K
Other net income (expense) 555K
Special income (charges) --0------------------0----------------
-Less：Restructuring and merger&acquisition --0------------------0----------------
Other non- operating income (expenses) --555K------------------------------------
Income before tax 137.59%21.56M410.31%7.89M220.50%8.28M142.03%7.89M91.47%-2.49M16.75%-57.37M87.64%-2.54M66.06%-6.87M-420.42%-18.76M-19.20%-29.19M
Income tax 3,186.14%3.32M-4,471.79%-1.71M18,690.63%6.01M-6,562.50%-1.03M221.43%45K105.72%101K-31.58%39K32K100.82%16K-89.55%14K
Net income 131.75%18.25M471.71%9.59M132.86%2.27M147.50%8.92M91.32%-2.53M14.41%-57.47M87.49%-2.58M65.90%-6.91M-1,039.38%-18.78M-18.60%-29.2M
Net income continuous Operations 131.75%18.25M471.71%9.59M132.86%2.27M147.50%8.92M91.32%-2.53M14.41%-57.47M87.49%-2.58M65.90%-6.91M-1,039.38%-18.78M-18.60%-29.2M
Minority interest income
Net income attributable to the parent company 131.75%18.25M471.71%9.59M132.86%2.27M147.50%8.92M91.32%-2.53M14.41%-57.47M87.49%-2.58M65.90%-6.91M-1,039.38%-18.78M-18.60%-29.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 131.75%18.25M471.71%9.59M132.86%2.27M147.50%8.92M91.32%-2.53M14.41%-57.47M87.49%-2.58M65.90%-6.91M-1,039.38%-18.78M-18.60%-29.2M
Basic earnings per share 130.84%0.66477.78%0.34130.77%0.08145.71%0.3291.82%-0.0917.05%-2.1488.46%-0.0966.23%-0.26-1,066.67%-0.7-13.40%-1.1
Diluted earnings per share 128.97%0.62455.56%0.32130.77%0.08144.29%0.3191.82%-0.0917.05%-2.1488.46%-0.0966.23%-0.26-1,066.67%-0.7-13.40%-1.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Shanghai Mobitech Technology
301173
+165.94%
WUHAN LAND
830779
+30.00%
BAWEI
837023
+29.99%
4
LWGF
831627
+29.99%
5
HAOMIAO TECHNOLOGY
831856
+29.97%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025